AML-324 Impact of Discharge Timing for Extended-Course Decitabine and Venetoclax in Acute Myeloid Leukemia (AML)
- Resource Type
- Abstract
- Source
- In
Clinical Lymphoma, Myeloma and Leukemia September 2023 23 Supplement 1:S290-S290 - Subject
- Language
- ISSN
- 2152-2650